Elizabeth Yeu-Lin's Insider Trades & SAST Disclosures
Elizabeth Yeu-Lin's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 15,314 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Elizabeth Yeu-Lin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 15,314 | 15,314 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 10,045 | 10,045 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Purchase of securities on an exchange or from another person at price $ 16.80 per share. | 15 Aug 2023 | 9,506 | 15,866 | - | 16.8 | 159,701 | Common Stock |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 2,000 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 1,703 | 1,703 | - | - | Common Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges